Citation: | LI Hong, LI Geng, LIU Xing, YU Hong. Clinical value of HE4 as a molecular marker for renal fibrosis[J]. Chinese Journal of General Practice, 2023, 21(11): 1924-1927. doi: 10.16766/j.cnki.issn.1674-4152.003259 |
[1] |
BIKBOV B, PURCELL C A, LEVEY A S, et al. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. The Lancet, 2020, 395(10225): 709-733. doi: 10.1016/S0140-6736(20)30045-3
|
[2] |
刘宇, 刘孜卓, 刘笑然. 慢性肾脏疾病治疗[J]. 中国药物与临床, 2021, 21(7): 1100-1102.
LIU Y, LIU Z Z, LIU X R. The treatment of chronic kidney disease treatment[J]. Chinese Remedies & Clinics, 2021, 21(7): 1100-1102.
|
[3] |
PANIZO S, MARTÍNEZ-ARIAS L, ALONSO-MONTES C, et al. Fibrosis in chronic kidney disease: pathogenesis and consequences[J]. Int J Mol Sci, 2021, 22(1): 408. doi: 10.3390/ijms22010408
|
[4] |
DOCHEZ V, CAILLON H, VAUCEL E, et al. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review[J]. J Ovarian Res, 2019, 12(1): 28. doi: 10.1186/s13048-019-0503-7
|
[5] |
KALANTAR-ZADEH K, JAFAR T H, NITSCH D, et al. Chronic kidney disease[J]. The lancet, 2021, 398(10302): 786-802. doi: 10.1016/S0140-6736(21)00519-5
|
[6] |
LIU Z, TAN R J, LIU Y. The many faces of matrix metalloproteinase-7 in kidney diseases[J]. Biomolecules, 2020, 10(6): 960. doi: 10.3390/biom10060960
|
[7] |
WEN Y, RUDEMILLER N P, ZHANG J, et al. TNF-α in T lymphocytes attenuates renal injury and fibrosis during nephrotoxic nephritis[J]. Am J Physiol Renal Physiol, 2020, 318(1): F107-F116. doi: 10.1152/ajprenal.00347.2019
|
[8] |
YI L, AI K, LI H, et al. CircRNA_30032 promotes renal fibrosis in UUO model mice via miRNA-96-5p/HBEGF/KRAS axis[J]. Aging(Albany NY), 2021, 13(9): 12780-12799.
|
[9] |
KIRCHHOFF C, HABBEN I, IVELL R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors[J]. Biol Reprod, 1991, 45(2): 350-357. doi: 10.1095/biolreprod45.2.350
|
[10] |
李秀义, 齐向明, 夏圆圆, 等. 血清人附睾蛋白4对慢性肾脏疾病的临床诊断价值[J]. 中华全科医学, 2022, 20(5): 789-792. doi: 10.16766/j.cnki.issn.1674-4152.002455
LI X Y, QI X M, XIA Y Y, et al. Clinical value of serum human epididymal protein 4 in the diagnosis of chronic kidney disease[J]. Chinese Journal of General Practice, 2022, 20(5): 789-792. doi: 10.16766/j.cnki.issn.1674-4152.002455
|
[11] |
OHKUMA R, YADA E, ISHIKAWA S, et al. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer[J]. Int J Oncol, 2021, 58(1): 57-69.
|
[12] |
MENG Z J, LI X J, LIU F, et al. Potential association between elevated serum human epididymis protein 4 and chronic kidney disease in female patients[J]. J Physiol Pharmacol, 2020. DOI: 10.26402/jpp.2020.6.10.
|
[13] |
桑国耀, 胡金伟, 张朝霞. 血清HE4在慢性肾脏疾病分期中的诊断价值[J]. 标记免疫分析与临床, 2019, 26(1): 40-43.
SANG G Y, HU J W, ZHANG Z X. The diagnostic value of serum HE4 in staging of chronic kidney disease[J]. Labeled Immunoassays and Clinical Medicine, 2019, 26(1): 40-43.
|
[14] |
ZHANG L, CHEN Y, WANG K. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis[J]. Curr Probl Cancer, 2019, 43(2): 135-144. doi: 10.1016/j.currproblcancer.2018.06.001
|
[15] |
HOU Y, LI F, CHEN J, et al. Clinical significance of serum human epididymis protein 4 in liver fibrosis: an experimental study[J]. Medicine(Baltimore), 2020, 99(48): e23428. DOI: 10.1097/MD.0000000000023428.
|
[16] |
ZHANG M, YUAN L, YAO F, et al. Human epididymis protein 4 concentration is not associated with liver fibrosis and cirrhosis in a case control study[J]. Clin Chim Acta, 2018, 484: 213-217. doi: 10.1016/j.cca.2018.05.051
|